Figure 2. Post-ablation standard-of-care and distribution of AF-related symptoms. (A) AAD prescription in 290 patients with information available at discharge (navy bar) and 12 months (orange bar). (B) Proportion of patients monitored for atrial arrhythmia recurrences during the 12-month follow-up period with one (navy), 2 (orange) or 3 or more (yellow-green) 12-lead ECGs, Holter monitors, and all combined methods for arrhythmia monitoring. Patients with continuous monitoring methods (pacemaker/implantable cardiac monitor) are also depicted in red. All patients, including patients with continuous monitoring devices, received ECG monitoring at least once during the follow-up period. (C) Distribution of patients reporting on the presence of pre-specified AF-related symptoms at baseline (navy bars) and at the 12-month (orange bars) follow-up visit.

AAD = anti-arrhythmic drug; AF = atrial fibrillation; ECG = electrocardiogram.